Clinical Trial Update: Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFOX alone, FOLFOX with bevacizumab, and FOLFOX with panitumumab in patients with resectable liver metastases from colorectal cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFOX
• Panitumumab (panitumumab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer Metastatic, Liver Metastases | Phase 2 | Status: TERMINATED